Timing of menopause is crucial

Norwegian researchers have investigated the link between age at menopause, age at first menstruation, and the risk of mild cognitive impairment (MCI) and dementia. Dementia affects women more often than men worldwide. Therefore, experts increasingly recognize that dementia prevention is a central priority for global...

Dementia Risk: Pregnancy Illnesses

Researchers from Ireland and Sweden have discovered that women who suffer from pregnancy poisoning appear to have a significantly increased future risk of vascular dementia. If dementia develops later in life, it may have been pre-empted in younger years, for example, during pregnancy. It has long been known...

Does migraine lead to dementia?

Korean researchers investigated whether there is a connection between migraines and dementia. After analyzing data from more than 11,000 dementia patients and over 45,700 control subjects, they found that women with a history of migraines have an increased risk of dementia. Generally, there is increasing evidence that women and men experience different...

Neuropsychiatric Symptoms in Women with Alzheimer's Dementia

Certain neuropsychiatric symptoms, such as depression and psychosis, occur more frequently in women with Alzheimer's dementia than in men with Alzheimer's dementia. This is one of the central findings of a study by researchers from the Netherlands, Sweden, the USA, Canada, and Australia. In people with Alzheimer's dementia (AD), neuropsychiatric...

Cognitive Reserve: Hope for Women

Not only consider dementia risk, but also analyze protective factors that reduce the risk of Alzheimer's dementia: Researchers from Canada and Sweden have investigated whether there are gender-specific differences regarding the so-called cognitive reserve. There is frequent discussion of risk factors that can promote the development of Alzheimer's dementia (AD). „Factors that the AD risk..."

digiDEM Bavaria HIGHLIGHT_02: New Drugs for Dementia – Is Our Healthcare System Prepared?

In the second part of our new special newsletter, SCHLAGLICHT – New Dementia Medications, Jana Rühl, a research associate at digiDEM Bavaria, discusses the publication by the research team led by Professor Sören Mattke from the University of Southern California. Today, we address the question of whether healthcare systems can even cope with the diagnostic requirements...

digiDEM Bavaria SPOTLIGHT_01: New Medications for Dementia

SPOTLIGHT – New Medications for Dementia – this is the name of our new series on new active ingredients for the treatment of Alzheimer's disease. We want to shed „spotlight“ on the multifaceted topic of „New Dementia Medications and Challenges for Everyday Care.“ These new medications are intended for people in the early stages of the disease or in the mild phase...

Dementia information from digital sources

Regarding dementia prevention, education is necessary. It is „still largely unknown among the population that and by what methods dementia can be prevented,“ write researchers from Germany. They investigated what dementia-related digital information materials are available. They also analyzed how the materials cover risk factors, treatment measures, and so-called decision aids such as...

Atrial fibrillation and dementia

Whether atrial fibrillation is a risk factor for cognitive impairment and dementia is currently intensely debated among medical professionals. Is the therapy of cardiac arrhythmias a protective factor against dementia? And which forms of therapy - rhythm control or heart rate reduction - are more effective in this regard? Researchers from China have found an answer to these questions. Their ...